Information Provided By:
Fly News Breaks for February 6, 2019
CMRX
Feb 6, 2019 | 11:32 EDT
After Chimerix announced that CEO M. Michelle Berrey has resigned, H.C. Wainwright analyst Edward White said he believes the company is "in good hands" while it will be led by the new Office of the CEO, comprised of CMO Garrett Nichols, CFO Timothy Trost, and General Counsel Michael Alrutz. He spoke with management, who indicated that the oral and intravenous brincidofovir and norovirus programs continue as per previous company guidance with no expected changes to any development timelines, said White, who keeps a Buy rating and $10 price target on Chimerix shares.
News For CMRX From the Last 2 Days
There are no results for your query CMRX